Lars G. Ekman's most recent trade in Prothena Corporation plc was a trade of 20,183 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 14, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Prothena Corporation plc | Lars G. Ekman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2025 | 20,183 | 20,183 | - | - | Stock Option (Right to Buy) | |
| Prothena Corporation plc | Lars G. Ekman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Prothena Corporation plc | Lars G. Ekman | Director, Chair of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2023 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Prothena Corporation plc | Lars G. Ekman | Director, Chair of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.41 per share. | 03 Jan 2023 | 15,834 | 16,077 (0%) | 0% | 6.4 | 101,496 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Lars G. Ekman | Director, Chair of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2023 | 15,834 | 0 | - | - | Stock Option (right to buy) | |
| Prothena Corporation plc | Lars G. Ekman | Director, Chair of the Board | Sale of securities on an exchange or to another person at price $ 56.33 per share. | 03 Jan 2023 | 6,621 | 3,148 (0%) | 0% | 56.3 | 372,970 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Lars G. Ekman | Director, Chair of the Board | Sale of securities on an exchange or to another person at price $ 54.15 per share. | 03 Jan 2023 | 3,411 | 12,666 (0%) | 0% | 54.2 | 184,707 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Lars G. Ekman | Director, Chair of the Board | Sale of securities on an exchange or to another person at price $ 55.35 per share. | 03 Jan 2023 | 2,897 | 9,769 (0%) | 0% | 55.3 | 160,341 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Lars G. Ekman | Director, Chair of the Board | Sale of securities on an exchange or to another person at price $ 58.67 per share. | 03 Jan 2023 | 1,523 | 322 (0%) | 0% | 58.7 | 89,353 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Lars G. Ekman | Director, Chair of the Board | Sale of securities on an exchange or to another person at price $ 56.98 per share. | 03 Jan 2023 | 1,303 | 1,845 (0%) | 0% | 57.0 | 74,244 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Lars G. Ekman | Director, Chair of the Board | Sale of securities on an exchange or to another person at price $ 60.84 per share. | 03 Jan 2023 | 69 | 243 (0%) | 0% | 60.8 | 4,198 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Lars G. Ekman | Director, Chair of the Board | Sale of securities on an exchange or to another person at price $ 59.50 per share. | 03 Jan 2023 | 10 | 312 (0%) | 0% | 59.5 | 595 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Lars G. Ekman | Director, Chair of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.41 per share. | 01 Dec 2022 | 15,834 | 16,077 (0%) | 0% | 6.4 | 101,496 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Lars G. Ekman | Director, Chair of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2022 | 15,834 | 15,834 | - | - | Stock Option (right to buy) | |
| Prothena Corporation plc | Lars G. Ekman | Director, Chair of the Board | Sale of securities on an exchange or to another person at price $ 61.28 per share. | 01 Dec 2022 | 9,813 | 6,264 (0%) | 0% | 61.3 | 601,388 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Lars G. Ekman | Director, Chair of the Board | Sale of securities on an exchange or to another person at price $ 62.12 per share. | 01 Dec 2022 | 6,021 | 243 (0%) | 0% | 62.1 | 374,018 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Lars G. Ekman | Director, Chair of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2022 | 15,833 | 31,668 | - | - | Stock Option (right to buy) | |
| Prothena Corporation plc | Lars G. Ekman | Director, Chair of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.41 per share. | 01 Nov 2022 | 15,833 | 16,076 (0%) | 0% | 6.4 | 101,490 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Lars G. Ekman | Director, Chair of the Board | Sale of securities on an exchange or to another person at price $ 62.01 per share. | 01 Nov 2022 | 9,143 | 6,933 (0%) | 0% | 62.0 | 566,953 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Lars G. Ekman | Director, Chair of the Board | Sale of securities on an exchange or to another person at price $ 64.26 per share. | 01 Nov 2022 | 3,312 | 1,904 (0%) | 0% | 64.3 | 212,824 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Lars G. Ekman | Director, Chair of the Board | Sale of securities on an exchange or to another person at price $ 62.91 per share. | 01 Nov 2022 | 1,717 | 5,216 (0%) | 0% | 62.9 | 108,013 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Lars G. Ekman | Director, Chair of the Board | Sale of securities on an exchange or to another person at price $ 64.94 per share. | 01 Nov 2022 | 1,661 | 243 (0%) | 0% | 64.9 | 107,868 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Lars G. Ekman | Director, Chair of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.41 per share. | 03 Oct 2022 | 15,833 | 16,076 (0%) | 0% | 6.4 | 101,490 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Lars G. Ekman | Director, Chair of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 15,833 | 47,501 | - | - | Stock Option (right to buy) | |
| Prothena Corporation plc | Lars G. Ekman | Director, Chair of the Board | Sale of securities on an exchange or to another person at price $ 62.10 per share. | 03 Oct 2022 | 6,355 | 1,936 (0%) | 0% | 62.1 | 394,677 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Lars G. Ekman | Director, Chair of the Board | Sale of securities on an exchange or to another person at price $ 61.07 per share. | 03 Oct 2022 | 4,277 | 8,291 (0%) | 0% | 61.1 | 261,208 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Lars G. Ekman | Director, Chair of the Board | Sale of securities on an exchange or to another person at price $ 60.32 per share. | 03 Oct 2022 | 3,508 | 12,568 (0%) | 0% | 60.3 | 211,604 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Lars G. Ekman | Director, Chair of the Board | Sale of securities on an exchange or to another person at price $ 62.96 per share. | 03 Oct 2022 | 1,693 | 243 (0%) | 0% | 63.0 | 106,593 | Ordinary Shares, par value $0.01 per share |
| Ultragenyx Pharmaceutical ... | Lars G. Ekman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2022 | 6,245 | 6,245 | - | - | Stock Option (Right to Buy) | |
| Ultragenyx Pharmaceutical ... | Lars G. Ekman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2022 | 3,300 | 17,745 (0%) | 0% | 0 | Common Stock | |
| Ultragenyx Pharmaceutical ... | Lars G. Ekman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2021 | 4,125 | 4,125 | - | - | Stock Option (Right to Buy) | |
| Ultragenyx Pharmaceutical ... | Lars G. Ekman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2021 | 2,145 | 14,445 (0%) | 0% | 0 | Common Stock | |
| Prothena Corporation plc | Lars G. Ekman | Director, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2021 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Prothena Corporation plc | Lars G. Ekman | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Feb 2021 | 15,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Prothena Corporation plc | Lars G. Ekman | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Feb 2021 | 15,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Prothena Corporation plc | Lars G. Ekman | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Feb 2021 | 12,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Prothena Corporation plc | Lars G. Ekman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2021 | 9,803 | 9,803 | - | - | Employee Stock Option (Right to Buy) | |
| Prothena Corporation plc | Lars G. Ekman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2021 | 8,426 | 8,426 | - | - | Employee Stock Option (Right to Buy) | |
| Prothena Corporation plc | Lars G. Ekman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2021 | 6,315 | 6,315 | - | - | Employee Stock Option (Right to Buy) |